'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): A prospective observational study

npj Primary Care Respiratory Medicine

Volumn 28, Issue 1, 2018, Pages

  Boer, L M ^a   Bischoff, E W ^a   Borgijink, X ^b,c   Vercoulen, J H ^a   Akkermans, R P ^a   Kerstjens, H A M ^b   Assendelft, W J ^a   Schermer, T R ^a,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c GELRE HOSPITALS   (Netherlands)

^d NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EXACERBATION FREE TIME; FATIGUE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SMOKING; SPIROMETRY; SYMPTOM; INCIDENCE; LUNG FUNCTION TEST; NETHERLANDS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; VITAL CAPACITY;

AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; MALE; NETHERLANDS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; VITAL CAPACITY;

EID: 85044923732     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/s41533-018-0079-5     Document Type: Article

References (30)

1. Rodriguez-Roisin, R. Toward a consensus definition for COPD exacerbations. Chest 117, 398S-401S (2000).
2. Donaldson, G. C. et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 192, 943-950 (2015).
3. Halpin, D. M. et al. Exacerbation frequency and course of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 7, 653-661 (2012).
4. Xu, W. et al. Negative impacts of unreported COPD exacerbations on healthrelated quality of life at 1 year. Eur. Respir. J. 35, 1022-1030 (2010).
5. Foo, J. et al. Continuing to confront COPD International Patient Survey: economic impact of COPD in 12 countries. PLoS One 11, e0152618 (2016).
6. Beeh, K. M. et al. Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respir. Res. 14, 116 (2013).
7. Suissa, S., Dell'Aniello, S. & Ernst, P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 67, 957-963 (2012).
8. Global Initiative for Chronic Obstructive Lung Disease (GOLD). GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: http://goldcopd. org (2017).
9. Trappenburg, J. C. et al. The impact of using different symptom-based exacerbation algorithms in patients with COPD. Eur. Respir. J. 37, 1260-1268 (2011).
10. Effing, T. W. et al. Definitions of exacerbations. Does it really matter in clinical trials on COPD Chest 136, 923 (2009).
11. Bischoff, E. W. et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax 66, 26-31 (2011).
12. Trappenburg, J. C. et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: A multicentre randomised controlled trial. Thorax 66, 977-984 (2011).
13. Nishimura, K. et al. Effect of exacerbations on health status in subjects with chronic obstructive pulmonary disease. Health Qual. Life Outcomes 7, 69 (2009).
14. Verhage, T. et al. Decline of health status sub-domains by exacerbations of chronic obstructive pulmonary disease: A prospective survey. Respiration 85, 236-243 (2013).
15. Seemungal, T. A., Donaldson, G. C., Bhowmik, A., Jeffries, D. J. & Wedzicha, J. A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 161, 1608-1613 (2000).
16. Aaron, S. D. et al. Time course and pattern of COPD exacerbation onset. Thorax 67, 238-243 (2012).
17. Effing, T., Kerstjens, H., van der Valk, P., Zielhuis, G. & van der Palen, J. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: The COPE II study. Thorax 64, 956-962 (2009).
18. Celli, B. R. et al. An Official American Thoracic Society/European Respiratory Society Statement: research questions in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 191, e4-e27 (2015).
19. Jonkman, N. H. et al. Do self-management interventions in COPD patients work and which patients benefit most An individual patient data meta-analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 2063-2074 (2016).
20. Bischoff, E. W. et al. Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ 345, e7642 (2012).
21. Bischoff, E. W. et al. Validity of an automated telephonic system to assess COPD exacerbation rates. Eur. Respir. J. 39, 1090-1096 (2012).
22. Erdal, M. et al. Incidence of utilization-and symptom-defined COPD exacerbations in hospital-and population-recruited patients. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 2099-2108 (2016).
23. Criner, G. J. et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 147, 894-942 (2015).
24. Jones, P. W., Quirk, F. H., Baveystock, C. M. & Littlejohns, P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 145, 1321-1327 (1992).
25. Daudey, L. et al. Health status in COPD cannot be measured by the St George's Respiratory Questionnaire alone: An evaluation of the underlying concepts of this questionnaire. Respir. Res. 11, 98 (2010).
26. Bestall, J. C. et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54, 581-586 (1999).
27. Fletcher, C. M., Elmes, P. C., Fairbairn, A. S. & Wood, C. H. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br. Med. J. 2, 257-266 (1959).
28. Schunemann, H. J. et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur. Respir. J. 25, 31-40 (2005).
29. Anthonisen, N. R. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 106, 196-204 (1987).
30. Seemungal, T. A. R. et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 157, 1418-1422 (1998).